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Congenital generalized lipodystrophy (CGL) is a rare
autosomal recessive disorder that is characterized by
near-complete absence of adipose tissue, which has
been reported in over 300 patients [1]. This condition in
affected individuals is usually recognized soon after
birth because of the appearance of prominent muscu-
lature and hirsutism. Patients show extreme hyper-
triglyceridemia, hyperinsulinemia and hepatomegaly
because of hepatic steatosis. More associated features
include voracious appetite, accelerated linear growth,
advanced bone age, acanthosis nigricans, and acro-
megaloid features [2,3]. Mutations that involve three
Received: Jan 18, 2010 Accepted: Apr 19, 2010
Address correspondence and reprint requests to:
Dr Mei-Chyn Chao, Division of Pediatric
Genetics, Endocrinology and Metabolism, Depart-
ment of Pediatrics, Kaohsiung Medical University
Hospital, 100 Tzyou 1st Road, Kaohsiung 807,
Taiwan.
E-mail: mcchao@kmu.edu.tw
A TAIWANESE BOY WITH CONGENITAL
GENERALIZED LIPODYSTROPHY CAUSED BY
HOMOZYGOUS ILE262FS MUTATION IN THE
BSCL2 GENE
Hsiu-Hui Huang,1 Tai-Heng Chen,2,3 Hui-Pin Hsiao,7,8 Chia-Tsuan Huang,1 Cheng-Chu Wang,5
Ya-Huei Shiau,5 and Mei-Chyn Chao4–6
1Department of Family Medicine, 2Division of Pediatric Emergency, Department of Emergency, 
Divisions of 3Pediatric Neurology and 4Pediatric Genetics, Endocrinology and Metabolism, 
Department of Pediatrics, and 5Genetic Counseling Center, Kaohsiung Medical University 
Hospital, and Departments of 6Medical Genetics, and 7Pediatrics College of Medicine, 
Kaohsiung Medical University, and 8Department of Pediatrics, Kaohsiung 
Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan.
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disease that is charac-
terized by a near-complete absence of adipose tissue from birth or early infancy. Mutations in the
BSCL2 gene are known to result in CGL2, a more severe phenotype than CGL1, with earlier
onset, more extensive fat loss and biochemical changes, more severe intellectual impairment, and
more severe cardiomyopathy. We report a 3-month-old Taiwanese boy with initial presentation of
a lack of subcutaneous fat, prominent musculature, generalized eruptive xanthomas, and extreme
hypertriglyceridemia. Absence of mechanical adipose tissue in the orbits and scalp was revealed
by head magnetic resonance imaging. Hepatomegaly was noticed, and histological examination of a
liver biopsy specimen suggested severe hepatic steatosis and periportal necrosis. However, echocar-
diography indicated no sign of cardiomyopathy and he showed no distinct intellectual impair-
ment that interfered with daily life. About 1 year later, abdominal computed tomography revealed
enlargement of kidneys. He had a homozygous insertion of a nucleotide, 783insG (Ile262fs muta-
tion), in exon 7 of the BSCL2 gene. We reviewed the genotype of CGL cases from Japan, India,
China and Taiwan, and found that BSCL2 is a major causative gene for CGL in Asian.
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different genes (AGPAT2, BSCL2, and CAVEOLIN1)
have been identified to underlie this rare disorder, with
the first two accounting for about 95% of reported
cases [4–7]. CGL due to BSCL2 mutation, designated
CGL2, appears to be a more severe disease than that
due to AGPAT2 mutation, designated CGL1, with in-
creased prevalence of cardiomyopathy and mild men-
tal retardation [8–10]. Both CGL1 and CGL2 subtypes
demonstrate a near-total absence of metabolically active
adipose tissue within subcutaneous, intra-abdominal,
bone marrow, and intrathoracic sites [10]. However,
mechanical adipose tissue in palms, soles, orbits,
scalp, and periarticular regions is absent in CGL2 but
not in CGL1 [11].
In the present study, we report the clinical pheno-
type and genetic alterations of a Taiwanese patient
with CGL2 and a homozygous Ile262fs mutation in the
BSCL2 gene. The cause of nephromegaly in CGL is
discussed, and clinical characteristics and genetic alter-
ations in Asian CGL cases are briefly reviewed.
CASE PRESENTATION
A 3-month-old boy was born at term to non-consan-
guineous Taiwanese parents. He was expected as one
of twins, but the other twin died in utero at gestational
age 12 weeks. At birth, our patient was referred to
our Genetic Counseling Center, where a lack of sub-
cutaneous fat, prominent musculature and generalized
eruptive xanthomas were seen (Figure 1). Hepato-
megaly with palpable liver at 3 cm below the right
costal margin was noticed on physical examination.
Biochemical investigations revealed normal liver
function (GOT = 44 IU/L, GPT = 34 IU/L), extreme
hypertriglyceridemia (7,289 mg/dL), hyperinsuline-
mia (82.6 μIU/mL), and low serum leptin (0.84 ng/
mL). The patient had a normal 46,XY karyotype.
Absence of mechanical adipose tissue in the orbits
and scalp was revealed by head magnetic resonance
imaging. Histological examination of a liver biopsy
specimen suggested severe hepatic steatosis (> 66%)
A B
C D
Figure 1. Clinical features of this patient with (A) typical pinched face; (B) lack of subcutaneous fat including buttocks; (C) prominent
musculature and hirsutism; and (D) eruptive xanthomas (arrows) on right knee.
and periportal necrosis (Figure 2). In addition to a
special dietary formula that contained medium to long
chain fatty acids, medical treatment with fenofibrate,
titrated from 50 mg per day, was given. The eruptive
xanthomas gradually diminished and the serum was
less lipemic with 217 mg/dL triglycerides. His vora-
cious appetite markedly decreased.
The patient was evaluated every 3 months. He
showed neither distinct intellectual impairment nor
profound developmental delay that interfered with
daily life. Echocardiography indicated no sign of car-
diomyopathy and bone age was compatible with his
chronologic age. However, abdominal computed to-
mography (CT) revealed enlargement of kidneys at
the age of 1 year 8 months (Figure 3) [12]. Before the
age of 17 months, CT scan and periodically performed
abdominal sonography had only revealed improving
hepatomegaly with normal kidney size.
For the genetic analysis, sequencing of the BSCL2
gene revealed a homozygous insertion of a nucleotide,
783insG (Figure 4), in exon 7 of the BSCL2 gene. This
resulted in a frameshift of codon 262, and was pre-
sumed to be followed with 11 amino acid residues
with a premature stop codon at 273(I262fsX273). His
mother’s second pregnancy was prenatally diag-
nosed with the same homozygous BSCL2 mutation
by chorionic villus sampling, and was terminated at
gestational age 16 weeks. Both the parents, although
not phenotypically affected, had a heterozygous
783insG mutation.
DISCUSSION
CGL is an autosomal recessive disorder that is cli-
nically characterized by near-complete absence of
adipose tissue. It was first genetically mapped to
chromosome 9q34, and is now designated as CGL1
BSCL2 mutation in congenital lipodystrophy
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Figure 2. Liver biopsy: grade 1 portal and lobular inflammatory
activity, stage 1 fibrosis, severe hepatic steatosis (> 66%) and
periportal necrosis (hematoxylin and eosin, original magnifica-
tion, 400×)
Figure 3. Computed tomography revealed enlargement of kidneys
at the age of 1 year 8 months, whereas hepatomegaly diminished.
The expected length according to his height (84 cm) was 4.5–6.7 cm
(mean = 5.6 cm) [12].
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Figure 4. Sequence of the BSCL2 gene from congenital generalized
lipodystrophy cases, including the patient and the next preg-
nancy which was prenatally diagnosed by chorionic villus sam-
pling and artificially aborted. A homozygous G insertion between
nucleotides 782 and 783 in exon 7 was seen in both CGL cases.
The heterozygous G insertion was noticed in both the parents
(the S is a mix of the normal sequence C and the inserted G).
and caused by mutations in AGPAT2 gene. Homoz-
ygosity mapping in CGL families from Lebanon and
Norway has identified a second locus on chromosome
11q13, now designated CGL2, which results from
BSCL2 mutations and have been reported in Europe,
the Middle East, and Asia. Our CGL case was found to
be homozygous for the mutation 783insG (Ile262fs)
in exon 7 of BSCL2. His parents, although not pheno-
typically affected, both carry one abnormal allele that
bears the same frameshift mutation (783insG) (Figure
4). Wu et al reported another Taiwanese CGL patient
who has two abnormal alleles that bear one frameshift
(783insG) mutation inherited from the maternal side,
and one transition (G565T) mutation from the paternal
side [13]. As described, mutations for CGL patients can
be homozygous or compound heterozygous, and most
of the BSCL2 mutations are nonsense or frameshift
mutations that are expected to cause loss of function
of the protein [9]. Reports from Japan, India, China
and Taiwan [9,13–18] indicate that BSCL2 is a major
causative gene for CGL in Asian (Table). However,
nearly 50% of CGL cases around the world have no
sequence mutation in either AGPAT2 or BSCL2 [19].
CGL2 is a more severe phenotype than CGL1, with
earlier onset, more extensive fat loss and biochemical
changes, more severe intellectual impairment, and
more severe cardiomyopathy. Our patient had all the
characteristic clinical features for CGL2 except for
mental retardation and cardiomyopathy. It is notable
that the correlation between BSCL2 mutation and intel-
lectual competency has varied according to previous
reports (Table). More recent studies have emphasized
the phenotypic and genetic heterogeneity among and
within ethnic groups with CGL.
Nephromegaly has been reported with CGL, but
the cause remains unclear. In some cases, there is a
tendency for lipid deposition in the kidneys [20].
However, CT of the enlarged kidneys in our present
case did not suggest lipid density. Furthermore, it is
notable that nephromegaly in our case was not noted
in early infancy, but developed 1 year later while serum
lipid level was much lower. Tsau et al hypothesized
that nephromegaly results from hyperplasia and/or
hypertrophy induced by long-term high levels of
hepatocyte growth factor stimulation [21]. The level
of plasma hepatocyte growth factor, the endogenous
response to compensate for liver injury, has been re-
ported to be greater in patients with more severe
hepatitis, which is consistent with our case. In our
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patient, severe neonatal steatohepatitis was validated
by histological analysis at the age of 3 months, and we
assumed that this was the possible cause of enlarge-
ment of kidneys at the age of 1 year 8 months.
In summary, the CGL case reported here had a
homozygous 783insG mutation in the BSCL2 gene,
which contributes to the formation of CGL in Taiwan.
As verified in our case, CGL2 is a more severe pheno-
type than CGL1. However, the absence of mental
abnormality in the present case of CGL2 implies that
intellectual ability is not a typical distinguishing
characteristic of CGL1. Nephromegaly reported with
CGL is possibly caused by severe neonatal steatohep-
atitis. Our brief review indicates that BSCL2 is a major
causative gene for CGL in Asian.
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BSCL2 基因上的 Ile262fs 同型突變在一台灣
先天性全身脂肪失養症男童
黃琇慧
1
  陳泰亨
2,3
  蕭惠彬
7,8
  黃洽鑽
1
  王禎鞠
5
  蕭雅慧
5
  趙美琴
4,5,6
高雄醫學大學附設醫院  
1
家庭醫學部  
2
急診部小兒急診科  
3
小兒科部小兒神經科  
4
小兒遺傳及內分泌新陳代謝科  
5
遺傳諮詢中心
高雄醫學大學  醫學系  
6
醫學遺傳學科  
7
小兒學科
8
高雄市立小港醫院  小兒科
先天性全身脂肪失養症是一罕見的染色體隱性遺傳疾病，特徵為出生後以及嬰兒早期
皮下脂肪開始近乎全身缺少。第二型先天性全身脂肪失養症較第一型嚴重，較早發
病，皮下脂肪缺少的範圍較廣，血清生化值的變化較大，易發生較嚴重的智能障礙以
及 較 嚴 重 的 心 肌 病 變， 目 前 所 知 BSCL2 基 因（Berardinelli-Seip congenital 
lipodystrophy 2基因）上的突變為導致第二型疾病的原因。本文報告一 3 個月大的台
灣男童，初期臨床表現為皮下脂肪缺乏，肌肉明顯，全身性的黃色脂肪瘤和極度的高
三酸甘油脂血症。頭部的核磁共振掃描顯示眼眶和頭皮等處的機械性脂肪組織缺乏。
理學檢查發現肝臟腫大，肝臟切片的病理檢查結果為嚴重的脂化和肝門周圍壞死。但
是心臟超音波的報告中並沒有顯示出心肌病變，也沒有影響日常生活的顯著智能障
礙。約 1 年後腹部的電腦斷層發現新產生的腎臟腫大。他在 BSCL2基因第七外序列上
有一個同型突變 — 在核苷酸 783 位置插入了一個鳥嘌呤（G，guanine），或 Ile262fs
突變。我們回顧了日本，印度，中國，台灣 CGL個案的基因型，揭示了 BSCL2是在
亞洲病例中造成先天性全身脂肪失養症主要的突變基因。
關鍵詞：BSCL2基因，先天性全身脂肪失養症，肝炎，腎臟腫大
（高雄醫誌 2010;26:615–20）
收文日期： 99 年 1 月 18 日
接受刊載： 99 年 4 月 19 日
通訊作者： 趙美琴醫師
高雄醫學大學附設醫院小兒科部小兒遺傳及內分泌新陳代謝科遺傳諮詢中心
高雄市三民區自由一路 100 號
